Therapeutic Areas

4 Key Considerations for Managing & Monitoring Neurology Clinical Trials

Neurology studies are highly complex. Explore the following 4 key considerations to successfully manage and monitor neurology trials.

January 6, 2022
View the Post

Ensuring Consistency in RECIST 1.1 Reads

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

December 15, 2021
View the Post

Medical Device Clinical Trials: Classification & Challenges

(Originally submitted to surfaces.org’s SurFACTS in Biomaterials Volume 26 Issue 3.) An overview of medical device clinical trials, discussing device classification and challenge unique from drug/biologics trials.

December 2, 2021
View the Post

Breast Cancer Clinical Trials: A Caregiver & Project Manager’s Perspective

Breast Cancer Clinical Trials: A Caregiver, Advocate, and Project Manager’s Perspective  “Being an advocate for my mother made a big difference,” Tamara said. “Some people might be going through this process alone, or may not be able to understand the whole disease. I feel I was fortunate to be able to put my oncology background...
November 15, 2021
View the Post

Immuno-Oncology Clinical Trial Considerations

What do you need to consider when managing/monitoring an immuno-oncology clinical trial? Download PharPoint’s fact book to learn more.

May 5, 2021
View the Post

DOWNLOAD: PharPoint’s Cardiovascular Experience

Download PharPoint’s cardiovascular experience overview to learn more about our expertise.

April 20, 2021
View the Post

DOWNLOAD: PharPoint’s Oncology Experience

Download PharPoint’s oncology experience overview to learn more about our expertise.

April 13, 2021
View the Post

DOWNLOAD: Infectious Disease Experience

Learn more about PharPoint’s extensive infectious disease experience & expertise.

April 1, 2021
View the Post

DOWNLOAD: PharPoint’s COVID-19 Experience

Learn more about PharPoint’s experience with COVID-19 clinical trials.

March 10, 2021
View the Post